Dr. Reddy's Laboratories shared important business announcements that could impact its growth trajectory.

Dr Reddys Laboratories has experienced a decisive breakout above its long-term descending trendline, indicating renewed bullish momentum with five consecutive weekly gains and a strong rise of nearly 6.16%. The stock is maintaining a higher-high and higher-low structure, with the RSI around 69, suggesting strong momentum, and a potential move towards 1,421 is likely, with a breakout above this level extending the rally towards 1,450.